Antipneumococcal activities of RP 59500 (quinupristin-dalfopristin), penicillin G, erythromycin, and sparfloxacin determined by MIC and rapid time-kill methodologies - Wikidata - awgldk - TriplyDB

Antipneumococcal activities of RP 59500 (quinupristin-dalfopristin), penicillin G, erythromycin, and sparfloxacin determined by MIC and rapid time-kill methodologies

Antipneumococcal activities of RP 59500 (quinupristin-dalfopristin), penicillin G, erythromycin, and sparfloxacin determined by MIC and rapid time-kill methodologies

http://www.wikidata.org/entity/Q35125580

about

Susceptibilities of penicillin- and erythromycin-susceptible and -resistant pneumococci to HMR 3647 (RU 66647), a new ketolide, compared with susceptibilities to 17 other agents Antipneumococcal activity of grepafloxacin compared to that of other agents by time-kill methodology.Activity of HMR 3647 compared to those of five agents against Haemophilus influenzae and moraxella catarrhalis by MIC determination and time-kill assay Antipneumococcal activities of gemifloxacin compared to those of nine other agents Antipneumococcal activities of GAR-936 (a new glycylcycline) compared to those of nine other agents against penicillin-susceptible and -resistant pneumococci.Antipneumococcal activity of ABT-773 compared to those of 10 other agents.Susceptibilities of Haemophilus influenzae and Moraxella catarrhalis to ABT-773 compared to their susceptibilities to 11 other agents MIC and time-kill study of antipneumococcal activities of RPR 106972 (a new oral streptogramin), RP 59500 (quinupristin-dalfopristin), pyostacine (RP 7293), penicillin G, cefotaxime, erythromycin, and clarithromycin against 10 penicillin-susceptible Influence of erythromycin resistance, inoculum growth phase, and incubation time on assessment of the bactericidal activity of RP 59500 (quinupristin-dalfopristin) against vancomycin-resistant Enterococcus faecium.Antipneumococcal activity of BAY 12-8039, a new quinolone, compared with activities of three other quinolones and four oral beta-lactams.Emergence of the M phenotype of erythromycin-resistant pneumococci in South Africa.In vitro selection of resistance to clinafloxacin, ciprofloxacin, and trovafloxacin in Streptococcus pneumoniae.Postantibiotic effect and postantibiotic sub-MIC effect of quinupristin-dalfopristin against gram-positive and -negative organisms.Antipneumococcal activity of BMS 284756 compared to those of six other agents.Antipneumococcal activity of ertapenem (MK-0826) compared to those of other agents.Resistance to macrolides and related antibiotics in Streptococcus pneumoniae

P2860

Q33691239-84E64331-D663-4F29-AF2A-AF0BD025CB45 Q33696166-57FEE2D1-0DFF-4DB5-AEF1-4668C7E332C7 Q33702256-15A8189F-6652-4DBF-8AD5-426B9EE2B0B9 Q33978679-65827813-BEE9-47C4-AD7A-C5C61E59BAC6 Q33979265-60623EF1-D251-45CA-A357-307A427C2C9F Q33980037-B852359A-AF39-405F-8C7D-416D27435BCE Q33981117-2FDDA29C-9C0C-405B-8459-1E776D313727 Q35126660-6862107C-8431-4277-BF95-D8C605A05653 Q35139489-2A0AF8A2-29F1-43C1-8A36-F17B181EAD9F Q35139557-85D35670-6823-4108-9AAF-56F1D8D5FBAF Q37092331-0B60BF6E-FBD5-40F0-BD11-AB4AFB58705B Q39475328-2B2DE670-8B80-4526-9BBE-F3646EED0BA0 Q39559533-4BCFC274-B5F3-4817-B101-622DD8B1DA6E Q39650891-F2E9F0FB-793D-48A3-8153-0BB155881792 Q39650917-14E05527-B900-4BA1-A5CB-FDDDE72C65FB Q39652725-F453BA92-0BC3-4456-B9C4-24A1B1630350

P2860

Antipneumococcal activities of RP 59500 (quinupristin-dalfopristin), penicillin G, erythromycin, and sparfloxacin determined by MIC and rapid time-kill methodologies

http://www.wikidata.org/entity/Q35125580

description

1996 nî lūn-bûn

@nan

1996 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

1996 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

1996年の論文

@ja

1996年論文

@yue

1996年論文

@zh-hant

1996年論文

@zh-hk

1996年論文

@zh-mo

1996年論文

@zh-tw

1996年论文

@wuu

name

Antipneumococcal activities of ...... rapid time-kill methodologies

@ast

Antipneumococcal activities of ...... rapid time-kill methodologies

@en

type

label

Antipneumococcal activities of ...... rapid time-kill methodologies

@ast

Antipneumococcal activities of ...... rapid time-kill methodologies

@en

prefLabel

Antipneumococcal activities of ...... rapid time-kill methodologies

@ast

Antipneumococcal activities of ...... rapid time-kill methodologies

@en

P1433

Q35125580-543A19F4-C54E-4AD8-AA23-9AFFCAC02396

P1476

Q35125580-63565C31-368B-444F-8024-97BBC7F91E87

P2093

Q35125580-A25E9159-DF50-4265-8086-6C553F8D6A21

Q35125580-BF78B7CB-20B4-4263-9259-909B9936B168

Q35125580-D39868DD-E6A7-4EFB-B819-1E2DEE1FA861

Q35125580-FCA7CB65-4CDB-4BD9-8D0D-A8B255CD3FDA

P2860

Q35125580-0E884B8A-F1E5-4AD0-88EA-97C5E2EF7A9B

Q35125580-2F55F765-CCDE-4A0F-9B85-3EECAFE2D4A2

Q35125580-35406986-811C-4406-8834-634FD1234F57

Q35125580-546FF5F7-6325-4D95-A22E-41501F452404

Q35125580-5C28A5E5-045B-4B93-A804-1ADF0E710111

Q35125580-631965E2-C19A-4112-8CBE-428B87A460A4

Q35125580-B81F9534-7A74-4DB1-AA9A-F1A1D6401706

Q35125580-BE8E1EF7-10DA-4D5D-8040-7B7508B8C21A

Q35125580-DAA13C22-46E9-42F9-8307-B035670EBA67

Q35125580-E2F58F83-7E7F-483E-995B-072C64216880

P304

Q35125580-6C6C2BB9-5CC4-4E43-848F-BB3D3EA917B3

P31

Q35125580-C7AA0955-F527-4566-AD11-70E19D3DF261

P356

Q35125580-8F61A45D-69C3-488D-94BB-225E762276B2

P407

Q35125580-79A03EB9-F5B4-405F-9B85-785F105A6389

P433

Q35125580-5C82C4F5-33CE-45F5-A745-C98DF7328B86

P478

Q35125580-BECA5DFA-0473-4C42-A255-AC4AF531B7FD

P577

Q35125580-5D764934-E163-4361-A47E-75530A2AAC0C

P698

Q35125580-81E9C1D5-524E-4CCA-A820-A624978DAE40

P932

Q35125580-0974DE7F-4A2B-4B3F-822F-9C348AB2D09E

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

Antipneumococcal activities of ...... rapid time-kill methodologies

@en

P2093

C Lichtenberger

http://www.w3.org/2001/XMLSchema#string

G A Pankuch

http://www.w3.org/2001/XMLSchema#string

M R Jacobs

http://www.w3.org/2001/XMLSchema#string

P C Appelbaum

http://www.w3.org/2001/XMLSchema#string

P2860

Study of comparative antipneumococcal activities of penicillin G, RP 59500, erythromycin, sparfloxacin, ciprofloxacin, and vancomycin by using time-kill methodology

In vitro activities of 12 orally administered antimicrobial agents against four species of bacterial respiratory pathogens from U.S. Medical Centers in 1992 and 1993.

Importance of bacterial growth phase in determining minimal bactericidal concentrations of penicillin and methicillin.

Susceptibilities of penicillin-susceptible and -resistant strains of Streptococcus pneumoniae to RP 59500, vancomycin, erythromycin, PD 131628, sparfloxacin, temafloxacin, win 57273, ofloxacin, and ciprofloxacin.

Increased rate of isolation of penicillin-resistant Streptococcus pneumoniae in a children's hospital and in vitro susceptibilities to antibiotics of potential therapeutic use.

Treatment and diagnosis of infections caused by drug-resistant Streptococcus pneumoniae.

Antimicrobial resistance in Streptococcus pneumoniae: an overview.

Management of infections caused by antibiotic-resistant Streptococcus pneumoniae.

Antimicrobial activity against Staphylococcus aureus of semisynthetic injectable streptogramins: RP 59500 and related compounds.

Activity of oral antibiotics in middle ear and sinus infections caused by penicillin-resistant Streptococcus pneumoniae: implications for treatment.

P304

1653-1656

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.40.7.1653

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

40

http://www.w3.org/2001/XMLSchema#string

P577

1996-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

8807057

http://www.w3.org/2001/XMLSchema#string

P932

163390

http://www.w3.org/2001/XMLSchema#string